Sophia, Advanced Humanoid
Hanson Robotics, Hong Kong
The future is here and her name is Sophia, the world’s very first humanoid celebrity. The host of the Tonight Show with Jimmy Fallon, Sophia has graced the cover of Elle magazine, appeared on Chinese television, spoken before the United Nations General Assembly and named the first non-human citizen of Saudi Arabia. Wowing awestruck audiences with her superhuman intelligence and advanced ability to read faces, empathize with emotions, understand the nuances of language and communicate with thousands of facial expressions, Sophia has discussed subjects ranging from “Will robots take over the world?” to how artificial intelligence could end hunger in developing nations. Sophia interacts with humans in a profoundly personal way, previewing a fast-approaching future where friendly, caring humanoids help us solve our most challenging problems to create a better world.
From Hong Kong to the U.S., Europe and Australia, Sophia has sung in concert, addressed audiences in Mandarin, debated the future of the human race (against another robot), and generated billions of views and social media interactions. She has also displayed her expansive tech knowledge and growing business savvy, meeting with leaders in the banking, insurance, automotive, property development, media and entertainment industries. A versatile and ingenious presenter who customizes her appearances with encyclopedic event-specific content, Sophia has appeared as a panel-member and speaker at high-level conferences, addressing how robotics and artificial intelligence will become an integral part of everyone’s everyday lives and work.
Sophia is the brain child of Dr. David Hanson of Hong Kong-based Hanson Robotics, a modern-day renaissance man who has built a reputation for creating the world’s most humanlike robots. A former Disney Imagineer, Dr. Hanson’s mission is to create genius machines that are smarter than humans and able to learn creativity, empathy and compassion.
Appearing alongside Dr. Hanson or on her own, Sophia enchants audiences with a captivating, interactive look at the awe-inspiring potential of AI and robotics. She also provides enlightening insights into the provocative moral and ethical questions that accompany non-human intelligent lifeforms. As both the state-of-the art in technology and the state-of-the-heart in human-humanoid relations, Sophia always draws a crowd and brings a unique and unforgettable experience to any event.
Mara Hank Moret
Boston University, USA
Rhoda Au is Professor of Anatomy & Neurobiology, Neurology and Epidemiology at Boston University Schools of Medicine and Public. She also currently serves as Director of Neuropsychology at the Framingham Heart Study, where she has been involved in research related to cognitive aging and dementia since 1990. Most recently, she has been exploring the potential of cognitive digital biomarkers and how “big data” analytics can better inform our understanding of Alzheimer’s disease pathways and treatment. Beyond Framingham, Dr. Au is focused on building multi-sector ecosystems to enable solutions for chronic disease prevention generally and optimizing brain health specifically and to move the primary focus of health technologies from precision medicine to a broader emphasis on precision health.
Actress/Film Producer, activist on Traumatic Brain Injury; WBP Ambassador, USA
Chéri Ballinger is a professional actress, fashion model, and movie producer who has appeared in numerous films, TV shows, and commercials and print advertisements worldwide. She got her start in film while being discovered as a young girl and placed in the iconic Disney film “The Parent Trap” in 1998. She has worked in film steadily ever since. For nearly ten years, she was the official spokesmodel of Sun Labs/Giselle Cosmetics, representing them in all global media and events. Her dedication, optimism, and strong work ethic allowed her to earn a Bachelor’s Degree from California State University while simultaneously working around the world. In 2014, Chéri suffered from a horrific accident that left her with a severe traumatic brain injury (TBI). After years of grueling physical and speech therapy, as well as the grim prospect that she would not be able to have a full life again, Chéri overcame all the odds against her. With her passion for her second chance at life and her effervescent personality, she is now back to work in Hollywood primarily producing movies while also focusing on her international philanthropy efforts. Her latest feature film is the much anticipated “Roe v Wade” to be released in mid-2019. While currently working on a number of other incredible films, she’s also now producing an exciting feature entitled “Lazarus”. Chéri is focused on producing films that bring both entertainment and positive messages to an international audience. In addition, she is now an international speaker and the official ambassador for the Women’s Brain Project based in Switzerland.
Beatrice Beck Schimmer
Director of the Medical University of Zurich, Switzerland
Prof. Dr Beatrice Beck Schimmer is full professor of anesthesiology at the University of Zürich (UZH). Currently she is Vice President Medicine at the UZH and in charge of the leadership and management of the Faculty of Medicine together with the dean and deputy dean. She is responsible for the strategic development of academic medicine at UZH in cooperation with the ETH Zurich and the four University hospitals.
Previously, she held the role of Vice Dean for Academic Career Development and Equal Opportunities at the Faculty of Medicine of the UZH.
She studied human medicine at the University of Bern and gained her habilitation at the University of Zurich in 2003. From 2005 to 2018, she was Chief of Service at the Department of Anesthesiology at the University Hospital Zurich. She has been a full professor of anesthesiology since 2009.
Director of Research, Lurie Center for Autism Mass General Hospital for Children, Boston, USA
Dr. Staci Bilbo is the Lurie Family Associate Professor of Pediatrics and Neuroscience at Harvard Medical School and the Director of Research for the Lurie Center for Autism at Massachusetts General Hospital for Children. Her research is broadly focused on the mechanisms by which the immune and endocrine systems interact with the brain to impact health and behavior. Current research in her laboratory focuses on understanding the consequences of early life events, including infection, stress, environmental toxins, and maternal obesity on neural and immune system development, with an emphasis on sexually-dimorphic disorders such as autism spectrum disorder. A particular focus of the work is on the resident immune cells of the brain, microglia, including sex differences in their development and function, and in response to early life inflammatory signals.
Medical Director, Barcelona Alzheimer Treatment & Research Center, Spain
Neurologist (Universitat de Barcelona,1972). PhD in 1993. Founder and medical director of Fundació ACE 1995. Distinguish professor of Universitat Internacional de Catalunya. Former President of the Catalan Society of Neurology (2000-2002).
Research Interest: Alzheimer’s disease and related dementias, including diagnosis, pharmacologic and non-pharmacologic treatment and basic, social, bioethical and legal research applied to the welfare and protection of people suffering dementia and their caregivers.
From 1996 to 2001, advisor on the bioethics committee of the Catalan Government, technical coordinator for the design of care model for people with cognitive impairment, and President of the committee for the Pharmacological Treatment for Alzheimer’s disease of the Catalan Government (CATMA).
Co-director Documento Sitges 1st and 2nd edition.
Member of the Executive Committee of the European Alzheimer’s Disease Consortium (EADC) and Member of European Institute of Womens Health (EIWH) Advisory Board.
Leader of several projects funded by the Spanish and Catalan Governments, European Union and private institutions: AES, H2020, EFSD, ERA-NET, IMI2, Fundació La Caixa, and Grifols.
To date, leader of more than 110 clinical trials as well as authorship of more than 220 articles, 36 book chapters and 12 books of medical outreach.
Among other awards, recipient of the Professional Excellence Award by the Medical Council of Catalonia (2008); the Josep Trueta Medal for Health Merit, from the Generalitat de Catalunya (2012); the highest honor conferred by the Catalan Government, the “Creude Sant Jordi” (St.George’s Cross) for her work in the field of Alzheimer’s disease (2014), and Honorable Member of the Spanish Society of Neurology.
DayOne Basel, Switzerland
Thomas Brenzikofer is Co-Founder and Manager of DayOne Healthcare Innovation at BaselArea.swiss. DayOne aims at building a world leading hub for precision medicine understood as the convergence of diagnostics, treatment and digital health. Prior to his role for DayOne at BaselArea.swiss Thomas Brenzikofer was Deputy CEO of i-net innovation networks switzerland. Thomas Brenzikofer has a professional background in journalism. from 2000 to 2010 he was the co-founder and Editor-in-Chief of Netzwoche covering the Topic of digital driven business innovation as IT magazine . After that he launched the “C-level Magazin” and the industry compendium “Swiss Made Software – the Book” as joint editor and author. He started out in journalism in 1993 as editor of “WerbeWoche“, the digital lifestyle magazine “Smile” and covered matters related to e-business, the internet, web-technology and the new economy as a partner in the ZBM Press Office contributing various daily newspapers on matters and magazins such as Cash, Facts an Bolero. Thomas Brenzikofer studied philosophy, linguistics and german literature at the University of Basel, specialising in semiotics.
University of Arizona, USA
Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona whose mission addresses neurodegenerative diseases of aging, Alzheimer’s, Multiple Sclerosis, Parkinson’s and ALS.
Brinton is an internationally recognized expert in the systems biology of Alzheimer’s disease and is developing the first regenerative therapeutic to regenerate the degenerated brain. Her analyses focused on the brain at greatest risk for Alzheimer’s, the aging female brain. Brinton’s research has shown that the aging brain undergoes a set of sequential bioenergetic and neuro-immune transitions that can lead to neurodegenerative disease. Further, her findings show that the sex difference in Alzheimer’s disease is not because women live longer than men, as commonly thought, but rather because the disease starts earlier in the female brain. Her insights into the transition states of the aging brain provide therapeutic opportunities to prevent, delay and treat neurodegenerative disease.
Brinton earned her Ph.D. as an NIH Predoctoral Fellow at the University of Arizona and went on to Rockefeller University as an NIH Postdoctoral Fellow. Subsequently, Brinton joined the University of Southern California faculty where she was Professor of Molecular Pharmacology, Biomedical Engineering and Neurology. Currently, Brinton is Professor of Pharmacology, Neuroscience and Neurology at the University of Arizona College of Medicine and Director of the Center for Innovation in Brain Science. She serves on the Alzheimer’s Drug Discovery Foundation Board of Governors and has serves on National Institute of Health scientific advisory boards and review panels. Her research has been continuously funded by the National Institutes of Health and for over two decades by the National Institute on Aging.
Brinton’s scientific research and STEM education endeavors have been recognized by numerous awards including Scientist of the Year by the Alzheimer’s Drug Development Foundation, Goodes Prize for Excellence in Alzheimer’s Drug Discovery, National Institute of Aging MERIT Award, the US Presidential Citizens Medal in 2010 and Ten Best Minds by US News and World Report.
University of Zurich, Switzerland
Thorsten Buch is director of the Insitute of Laboratory Animal Science at the Vetsuisse Faculty of the University of Zurich
The institute is the largest provider of the legally required courses for animal experimentators in Switzerland, with a new set of courses targeted towards reproducibility and quality of science.
Also in his curricular teaching he is enaging strongly in the topic of animal ethics and experimental design.
Thorsten Buch has been working since 1994 on immunological tolerance, with a strong neuroimmunological focus. The research projects in his institute are frequently interdisciplinary and geared towards bridging the whole spectrum from basic reasearch to actual translation in a spin-off.
Thorsten Buch is member of the Commission for Sex and Gender in Medicine at the University of Zurich.
International Corporate Affairs Pain Platform and Alzheimer’s disease Eli Lylli Global, USA
Laura Campo is responsible for the out-of-US relationships with Patient Associations and Health Professionals in the Global Corporate Affairs division at Eli Lilly and Company. In her role, Laura coordinates Lilly’s efforts to engage the external environment in Alzheimer’s disease, Migraine and Pain.
Before joining the International Corporate Affairs role, Laura served as Corporate Affairs Market Access Manager at Eli Lilly Italia, supporting the Regional access plans in the Oncology, Cardiovascular, CNS, and other therapeutic areas, with a special focus on the partnership programs with Regional Institutions on the optimization of NHS processes.
During the years in the Italian Corporate Affairs Division, Laura also covered the role of Country Leader for two major Lilly efforts in the environment engagement space, raising the attention to public policy issues that limit the access to patient’s care in the Oncology area and in the Alzheimer’s disease area.
In the previous years within Eli Lilly and Company, Laura covered other National and International roles as Marketing Manager in the Attention Deficit & Hyperactivity Disorder area in Lilly Italia, European Regulatory Affairs Manager in the UK and Research Scientist in the Lilly Research Laboratories (Indianapolis).
Laura pursued a post-doctoral fellowship at the University of Alabama at Birmingham and her graduate school in Italy where she currently lives.
Director Corporate Affairs, Microsoft Switzerland
Ladina Caduff is Director Corporate Affairs at Microsoft Switzerland, advocating for Microsoft’s public policy positions before policymakers and civil society. She’s also responsible for the creation and management of Microsoft’s constituency relations programs and works directly with civic associations and advocacy organizations. Before joining Microsoft in 2017, Ladina worked in advisory services at EY and later as Head Sustainability for Raiffeisen Switzerland. Ladina Caduff holds a PhD in political economy from University of Zurich. She worked as a senior researcher at ETH and the London School of Economics on sustainability and technology policy.
Founder and CEO of Forestay River Consulting Ldt, Switzerland
Tania Dussey-Cavassini combines nearly 30 years of hands on experience in global health, diplomacy, business consulting, executive education and law enforcement with strong exposure to companies ranging from global services, life sciences, consumer products to heavy industries. As Ambassador for Global Health and Vice-Director General of the Swiss Federal Office of Public Health, in charge of International Affairs (2013-2017), Tania advocated for the transfer of ideas and best practices to enhance the Swiss Health System. Tania is a Harvard Fellow (2012-2013). She was educated in management at IMD, in law at the University of Lausanne, and music at the University of Music Lausanne. She is a certified coach with The Actor’s Institute, New York. Tania serves on the Board of Directors of the Here-Geneva Foundation (Humanitarian Exchange and Research Centre). She is member of the Advisory Board of The Women’s Brain Project, promoting gender-based research. She is the founder and CEO of Forestay River Consulting Ldt.
Chair, Global Alliance on Women’s Brain Health, USA
Meryl Comer is a co-founder of Women Against Alzheimer’s/USA2 Network and a founding partner of The Global Alliance on Women’s Brain Health. For more than a decade (2007- 2019), Ms. Comer served as President and CEO of the Geoffrey Beene Foundation Alzheimer’s Initiative, a catalyst funder with a vision toward the future, targeting AD prevention through spirited public engagement campaigns, early assessment technologies, support of the first “virtual registry” as a power pool for big data, champion of AD patient and caregivers, and pre-clinical AD research to modify disease risk. She serves on the NIH National Advisory Council on Aging (NACA).
Vice-President of the European Stroke Organization, University of Lille, France
Prof. Charlotte Cordonnier, MD, PhD, is a neurologist specialised in stroke medicine. Appointed as Professor of Neurology at the Lille University (France) in 2012, she is the head of the department of Neurology & Stroke centre of the Lille University Hospital. Her research interests are intracerebral haemorrhages (including microbleeds) both in the setting of stroke and dementia, acute management of stroke, and stroke specificities in women. She is the director of the Lille Haemorrhagic Stroke research program inside the INSERM U1171. She has been a member of the Institut Universitaire de France since 2015, and serves as vice-president of the European Stroke Organisation (2016-2020). She is one of the founding members of the Women Initiative for Stroke in Europe (WISE).
Reader in Forensic & Neurodevelopmental Psychiatry, UK
Dr Craig completed a dual training in Psychiatry (FRCPsych) and Obstetrics & Gynaecology (FRCOG). He was subsequently awarded an MRC(UK) Clinical Training Fellowship to complete a PhD into the effects of sex hormones on the brain using in vivo brain imaging. His research and clinical interests remain focused on translational aspects of reproductive and neurodevelopmental psychiatry. He is Director of the National Female Hormone Clinic at the Maudsley Hospital and Reader in Neurodevelopmental Psychiatry at the IoPPN, Kings College London.
Co-Founder, Ellpha Project, EU
Stephanie is the CEO and co-founder of Ellpha, the first Artificial Intelligence program designed to detect and help fight gender bias in content, systems or processes.
She trained as an Aeronautics engineer in Ecole Centrale Paris and has always had a passion for science, data and technology. After working in the Aeronautics industry, she spent 20 years in the fmcg industry leading global strategic insights teams and understanding the consumers psychology and behaviours behind market growth.
The science around unconscious bias resonates with Stephanie’s own life experience as a daughter, sister, mother and passionate manager & mentor of women in the workplace.
In 2017 this instilled her drive to use data and AI to accelerate reaching gender parity and co-found the ellpha project.
European Institute for Women’s Health (EIWH)
Maeve Cusack is employed with the National Cancer Control Programme in Ireland as Surgical Oncology General Manager. She has extensive experience working in the health services both nationally and internationally. As General Manager for Surgical Oncology Maeve coordinates several programmes including the National Clinical Leads Network for Symptomatic Breast Disease (SBD). She works across the Surgical Clinical Programmes managing planning and implementing priority projects in accordance with national plans, policies and guidelines. Maeve works with the multidisciplinary teams in the National Cancer Centres to contribute and oversee the development and continuous improvement of cancer services in line with the National Cancer Strategy recommendations. In her previous role in the Irish National Screening Service (NSS) Maeve was responsible for the planning, development and implementation of the Screening/Health Promotion function and played an integral role in supporting population participation in the four national screening programmes. A key focus of this work was on the wider determinants of health and communicating screening messages to a diverse population. Working as part of a multidisciplinary team she played an integral role in supporting individuals to participate in the national screening programmes. She advised the NSS on strategy in relation to the best international evidence on interventions that promote participation and links with external national bodies from across the health care professions. Maeve has been a board member of the European Institute of Women’s Health (EIWH) for the past 4 years and has contributed to several high level policy briefs and also presented to the European Council on the topic of national population-based cervical screening programmes. Maeve began her career as a nurse working in Cardiac Intensive Care Units. Her academic achievements include a degree in Psychology and a Masters in Primary Health Care.
WBP Ambassador & actress, Switzerland
Sylvia is an international comedian, actress, writer and all-around entertainer. Based in Zurich and born in the US to Swiss-Brazilian parents, she is fluent in five languages, has a BA in Communications & Theater, and trained at the world’s top improv schools in Chicago, New York and London. Sylvia’s original comedy shows have been a hit with English-speaking audiences around the world including Zurich, Chicago and Off-Broadway. Her most recent one-woman show, the political comedy “50 Shades of (Election) DAY!” premiered at Zurich’s Kaufleuten and was aired on national news – SRF1 Tagesschau. A TEDx speaker, Sylvia also offers communication coaching and workshops to groups and individuals and can be booked for private and corporate events.
Elena Ruiz de la Torre
European Migraine & Headache Alliance, Executive Director
Winner of the THE ONE International Humanitarian Award, Founder of The Mauli House, India
He is from India. Education: M. D. (Homoeopathy), M. A. (Clinical Psychology), PGDEMS (Post graduate diploma in emergency medical services), NTMC (National trauma management course)
Name of Organization: Mauli Seva Pratishthan (MAULI HOUSE), Designation- Chief Functionary / President
Work: Working for wondering, homeless mentally ill women and their children found on road. Providing Lifelong care and home. Taking care of pregnant women who are abused mentally and physically. Conducting labor of such homeless, destitute pregnant women and taking lifelong care of them and their children. Currently there are 160 women and 21 children which are born in MAULI. Taking care of destitute women having dreadful diseases and critical illnesses, such as tuberculosis, HIV AIDS, venereal diseases, cardiac and metabolic diseases. Running and managing first of its kind intensive care unit for homeless, destitute women who are abandon by their families on road to die. Construction of 600 bed MANGAV project phase first is completed now with inmate capacity of 120 women. Total 500 homeless mentally and physically ill women will get lifelong home and 100 bed super specialty hospital for critically ill and dying who are found on road. He is also founder and President of NNG INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES INDIA. This institute is an autonomous institute and one of its kind dedicated for research and development in the field of mental health and neurosciences in India. He is Writer and filmmaker made many documentaries and films on social issues. Many documentaries made by him showcased in well-known International film festivals around the globe.
Professor of Psychiatry and Behavioral Sciences, Duke Center for Applied Genomics and Precision Medicine, Duke University, Co-chair, World Economic Forum Global Future Council on Neurotechnology, USA
Dr. Murali Doraiswamy is a physician-scientist at Duke University where his research focuses on precision medicine and digital health. He also serves as an advisor to leading government agencies, businesses and advocacy groups. He is a member of the World Economic Forum’s Global Future Councils and co-author of a popular book, The Alzheimer’s Action Plan.
Author of the book “Doing Harm”, USA
Maya Dusenbery is an American journalist and author of the book Doing Harm: The Truth About How Bad Medicine and Lazy Science Leave Women Dismissed, Misdiagnosed, and Sick. She is editorial director of the award-winning site Feministing.com and was formerly a fellow at Mother Jones magazine and a columnist at Pacific Standard. Her writing has appeared at Slate, The Atlantic, HuffPost, Cosmopolitan, Popular Science, and more. Before becoming a full-time writer, she worked at the National Institute for Reproductive Health. A Minnesota native, she is currently based in Portland, Oregon.
Senior vice President of Neuroscience-20, Verticai Consulting and Ventures, Switzerland
Christoph Ebell is an entrepreneur, science diplomat, technology consultant and transformation strategist. He was born in Bern in 1972. He first studied physics, then humanities and graduated in Bern and Chicago. After a research stay in Cambridge (USA), he worked for the Swiss government’s innovation agency CTI, then for the Swiss Interior, Economy, and Foreign Affairs Departments and was transferred to head the Science Section at the Swiss Embassy in Washington, D.C. Back in Switzerland, he worked for the Human Brain Project, a multidisciplinary EU project in computer-based brain research and the largest of its kind in Europe, for the last 3 years as its Executive Director. In 2018 Chris Ebell established a consulting firm for technology projects and venture capital, and is mandated as COO of a German software company for next generation High Performance Computing. He speaks frequently at international events. He is based in Geneva, Switzerland.
Maria Teresa Ferretti
Chief Scientific Officer, WBP, Switzerland
After growing up in Sardinia (Italy) my studies led me to Spain, England, Canada and finally Switzerland.
Here I am currently a junior group leader at University of Zurich working on biomedical research in the field of Alzheimer’s disease.
My goals are to help finding a cure for this devastating disease and to support the lives of Alzheimer’s patients and caregivers. It was shocking to learn that both are overwhelmingly women. Therefore I enthusiastically joined the Women’s Brain Project organization as a vehicle to promote gender-related science and advocate for actions in support of caregivers.
University of British Columbia, Canada
Liisa Galea is a Professor in the Department of Psychology, a member of the Centre for Brain Health, Director of the Graduate Program in Neuroscience, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. My research investigates how sex hormones influence brain health and disease in both females and males. The main goal of my research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
Director of Neurolimbic Research, Martinos Center for Biomedical Imaging at Massachusetts General Hospital and Harvard Medical School, Boston, USA
Nouchine Hadjikhani, MD, PhD, is Associate Professor in Radiology at Harvard Medical School, where she directs the Neurolimbic Research Laboratory. She is also an Assistant in Neurosciences at the Massachusetts General Hospital and Visiting Professor at GNC, Gothenburg University, Sweden. She is an author of 105 peer-review articles and 14 books, book chapters and other publications.
She has been doing brain imaging for more than twenty years, using neuroanatomy, histology, Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), magnetoencephalography (MEG) as well as behavioral methods, including eye-tracking, to study the normal and the diseased brain. Her research stems from her interest of the visual system and include conditions such as migraine and autism.
Institute for Ethics and Emerging Technologies, Trinity College in Hartford, Connecticut, USA
James Hughes Ph.D. is a bioethicist and sociologist who serves as the Associate Provost for the University of Massachusetts Boston (UMB), and as Senior Research Fellow at UMB’s Center for Applied Ethics. He holds a doctorate in Sociology from the University of Chicago where he taught bioethics at the MacLean Center for Clinical Medical Ethics. Since then Dr. Hughes has taught health policy, bioethics, medical sociology and research methods at Northwestern University, the University of Connecticut, and Trinity College. Dr. Hughes is author of Citizen Cyborg: Why Democratic Societies Must Respond to the Redesigned Human of the Future (2004) and is co-editor of Surviving the Machine Age: Intelligent Technology and the Transformation of Human Work (2017). In 2005 Dr. Hughes co-founded the Institute for Ethics and Emerging Technologies (IEET) with Oxford philosopher Nick Bostrom, and since then has served as its Executive Director. Dr. Hughes serves as Associate Editor of the Journal of Evolution and Technology, and as co-founder of the Journal of Posthuman Studies. Dr. Hughes speaks on medical ethics, health care policy and future studies worldwide.
Singularity University, Switzerland
Nicoletta Iacobacci, PhD, is an ethical influencer who engages executives, thinkers, artists, innovators, entrepreneurs, and students in conversations about ethics and emerging technologies. She is the founder of Ethica.ly, a platform for engaging reflections on the consequences of exponential innovations, and currently serves as an adjunct professor at Webster University Geneva and at Jinan University in Guangzhou, China, where she is investigating the future implications of technology on society. She has been a resident at the Rockefeller Foundation Bellagio Center, a curator of TEDx events, the Ambassador for Singularity University Geneva, and the leader of the ethical framework for Hyperloop Transportation Technology. Her book Exponential Ethics, supported by the Rockefeller Foundation, has been just released.
Atlantic Fellow, Global Brain Health Institute,Trinity College Dublin, Ireland
Stefania Ilinca PhD. is an Atlantic Fellow with the Global Brain Health Institute, based in Trinity College Dublin and a researcher at the European Centre for Social Welfare Policy and Research in Vienna. Her research focuses on discrimination and inequity in access to health and long-term care, with particular attention to intersecting inequalities and vulnerable population groups. Her work aims to inform policy on the challenges and opportunities posed by demographic ageing and associated prevalence of chronic and neuro-degenerative diseases, for health and social care systems in Europe and beyond. She has extensive experience in designing, implementing and disseminating results for research projects in the fields of health economics, health policy and public health.
President, European Federation of Neurological Associations (EFNA)
Joke Jaarsma is currently President of the European Federation of Neurological Associations (EFNA) as well as Treasurer of the European Brain Council (EBC). In her work for both organisations she is actively involved in creating more awareness for brain diseases, specifically neurological illness, within the European institutions, by working in close contact with the scientific community, and by engaging with all other stakeholders. She is a member of the Guidelines Production Group at the European Academy of Neurological Associations, as well as of the scientific panels on palliative care and Sleep. Joke is actively engaged in EBC’s major research project The Value of Treatment.
Executive Director Mary Horrigan Connors Center for Women’s Health and Gender Biology, Vice Chair for Research, Department of Psychiatry Brigham and Women’s Hospital, USA
Dr. Joffe is the Paula A. Johnson Associate Professor of Psychiatry in the Field of Women’s Health at Harvard Medical School, Executive Director of the Connors Center for Women’s Health and Gender Biology at Brigham & Women’s Hospital, and Director of the Women’s Hormones and Aging Research Program. Dr. Joffe is an experienced clinician and clinical reproductive neuroscientist in women’s aging and mental health. Her work focuses on the mechanisms, course, and treatment of menopausal symptoms (hot flashes, insomnia, depression, fatigue) in healthy women and breast cancer survivors. For 20 years, she has been funded by the NIH and pharmaceutical companies. The Connors Center goal is to ignite change in sex/gender medicine, including through their First-in-Women Precision Medicine Platform.
CNN Money Switzerland
Amanda Kayne is a news anchor at CNNMoney Switzerland. In 2011 she joined Julius Baer as the communications face of the bank and to lead its global future trends initiative. Previously, the British native was a journalist for the BBC’s World Business report and a reporter for CNBC Europe. She began her career as a current affairs presenter for the news network Russia Today. She holds postgraduate diplomas in economics from the London School of Economics and in print journalism from the National Council for the training of Journalists UK.
Digital Endpoints Development, Roche, Switzerland
Petranka holds a PhD in Neurosciences with research focused on molecular mechanisms of neurodegeneration in Parkinson’s Diasease (PD). In 2010 she joined the neuroscience research group at Novartis, to continue research and drug discovery in Parkinson’s and Alzheimer’s disease. Petranka then moved into translational clinical sciences working on early development studies in the areas of Autoimmunity, Musculoskeletal Diseases and Neuroscience. Attracted by the potential of mobile sensor technology, she has contributed to a number of Proof-of-concept clinical studies leveraging innovative digital technologies. As a Digital Biomarker Science and Study Lead at Roche (pREDi Digital Biomarker area), Petranka is working at the interface between the pREDi Digital Biomarker teams and the global drug development teams to drive the implementation of Remote Patient Monitoring solutions with focus on Multiple Sclerosis.
Wyss Center for Bio and Neuroengineering, Switzerland
Dr Tracy Laabs is the Deputy Director of the Wyss Center for Bio and Neuroengineering, Geneva, Switzerland, a non-profit foundation that accelerates neurotechnology for human benefit. Dr Laabs has over fifteen years of combined professional and research experience in multiple life science. Prior to joining the Wyss Center, she was a Senior Scientist at Strategic Analysis, Inc. where she provided technical expertise and scientific program management support on neuroscience and neurotechnology programs at the US Defense Advanced Research Projects Agency (DARPA). Dr Laabs has experience in strategic planning, development and management of high risk/high reward multidisciplinary programs and coordinating interdisciplinary teams of academic and industrial scientists in the development of neurotechnologies. She holds a PhD in Neuroscience from the University of Cambridge (UK) and a BS in Pharmacology and Toxicology from the University of Wisconsin-Madison (US).
CNS working party member EMA
Valentina Mantua is a medical doctor and a psychiatrist with an extensive clinical experience in the field of psychosis and affective disorders both at the Maudsley NHS Trust in London and University Hospital in Pisa, Italy, where she also obtained a PhD in Neurobiology of Affective Disorders. She joined the regulatory world in 2012 as expert CNS assessor at the Italian Medicines Agency (AIFA) and served as Italian representative in several working parties at the European Medicines Agency (EMA): the Scientific Advice Working Party (SAWP) and the Central Nervous System Working Party on (CNSWP). She is also the Italian representative at the EU-Innovation Network, supporting innovation in drug development both at a national and European level.
Director, Interactive Robots and Media Lab MIT, USA
Nikolaos Mavridis, PhD from the Massachusetts Institute of Technology (MIT), is an Academic and Consultant specializing in Robotics and Artificial Intelligence. He is the founder and director of the Interactive Robots and Media Lab (IRML), and has served as faculty at numerous institutions, including New York University (NYU) AD, the National Center for Scientific Research Demokritos, and others. His interests include intelligent robots, and especially verbal and non-verbal communication with robots, artificial intelligence, machine learning, and cognitive systems. He has served in numerous leadership and pro-bono positions, has been a TEDx Speaker four times, including Geneva and Athens, and is a member of the MIT Education Council and a mentor for the MIT Enterprise Forum.
Director, Women’s Brain Initiative; and Associate Director, Alzheimer’s Prevention Clinic at Weill Cornell Medical College, New York, USA
Dr. Lisa Mosconi, PhD, is Associate Professor of Neuroscience in Neurology at Weill Cornell Medical College (WCMC)/NewYork-Presbyterian Hospital, where she serves as Director of the Women’s Brain Initiative (WBI) research program and Associate Director of the WCMC Alzheimer’s Prevention Clinic. She also is an adjunct faculty member at the Department of Psychiatry at NYU School of Medicine, and at the Department of Nutrition at NYU Steinhardt School of Nutrition and Public Health. Dr. Mosconi is well known for her research on the early detection of Alzheimer’s disease in at-risk individuals, women in particular, using brain imaging techniques such as PET and MRI.
Director of Women’s Neurology, Clinical Director of the Neurosciences Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, USA
I am an expert in Women’s Neurology. My contributions include both patient and physician education. I planned and designed a patient-oriented web site. I organize a CME accredited monthly multispecialty conference in a variety of aspects of women’s neurology. I’ve written multiple chapters and papers on this subject. I have edited several books including: “Neurological Illness in Pregnancy”, “Women’s Neurology- what do I do now?”, the Neurologic Clinics edition on the “Neurology of Pregnancy” and “Neurology and Psychiatry of Women: A Guide to Gender-based Issues in Evaluation, Diagnosis, and Treatment”. I direct a Harvard Medical School course in Women’s Neurology and Psychiatry and for many years directed the Neurology of Pregnancy course at the American Academy of Neurology. In addition, I co-direct an obstetrical neurology course. In the venue of seeing primarily women, I’ve become interested in functional neurological disorders, FNDs, and partnered with my colleagues in epilepsy and neuropsychiatry to establish a FND clinic and weekly conference.
Associate Professor of Psychiatry Director, Women’s Mood Disorders Center Johns Hopkins School of Medicine, USA
Dr. Payne is an Associate Professor of Psychiatry and the Director of the Johns Hopkins Women’s Mood Disorders Center. She received her medical degree from Washington University, completed her residency in psychiatry at Johns Hopkins and finished a fellowship in mood disorders through the Mood and Anxiety Disorders Program at NIH. In addition to providing outstanding clinical care for women with mood disorders, Dr. Payne conducts research into the genetic, biological, and environmental factors involved in postpartum depression and studies best practices for the management of mood disorders during and after pregnancy. She and her colleagues have recently identified two epigenetic biomarkers of postpartum depression and are working hard to replicate this work with NIH funding.
National Institute on Aging – Program director in the Division of Neuroscience, USADr. Petanceska is a Senior Advisor for strategic development and partnerships and a Program Director for systems biology and systems pharmacology in the Division of Neuroscience at the National Institute on Aging (NIA). She was instrumental for the development of NIA’s Alzheimer’s Disease (AD) Translational Research Program and leads NIA’s open-science, systems biology programs for target and biomarker discovery: the AMP-AD Target Discovery and Preclinical Validation Project and the M2OVE-AD and Resilience-AD Consortia. She also leads the Institute’s funding initiative focused on applying, integrative, data-driven approaches to understand the impact of sex differences on the molecular mechanisms underlying AD risk and responsiveness to treatment.
a patient living with Alzheimer’s disease & WBP Ambassador, Sweden
I am a woman of 43 years, who has been impacted by Alzheimer’s Disease for more than half of my life. My grandmother was buried during my first year and the autopsy showed Alzheimer’s. When I was 14 my father was affected by the disease and eventually died in 1999. His seven years younger brother died seven years after in the same disease.
I am thus committed to educate people about the Alzheimer’s Disease. With money from the Swedish Alzheimer Association I was able together with two other persons to make a film about being young and related to this disease.
I could not have imagined that seventeen years after my father’s death, I would receive the news that I was affected as well! l At the age of 39.
Unfortunately, I had to struggle at first to believed by doctors. When I passed most of the standardized tests, the doctors said that it was nothing to be worried about. I had to change doctors twice! But I finally got the help, when I got in contact with my father’s old retired doctor.. While the medical investigation was going on, I studied to be a health educator and managed a three-year education at the university.
My goal is to write about the many challenges of young-onset Alzheimer’s patients, and especially women’s encounters.
Read my stories @ “Sofia’s Corner”
University Hospital Barcelona, Spain
Patricia Pozo-Rosich MD PhD, is a specialist in Neurology. She is in charge of the Headache and Craniofacial Pain Clinical Unit at the University Hospital Vall d’Hebron in Barcelona, Spain; and the Headache Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which belongs to the Universitat Autonoma of Barcelona (UAB).
After winning the la Caixa, American Headache Society, Rio Hortega, EFNS, research awards she became a Fellow in Preclinical Research with Professor Silberstein at the Thomas Jefferson University in Philadelphia (PA, USA) and later on with Professor Goadsby both at Queen’s Square – University College London (UK)– and at the University of California at San Francisco (CA, USA).
She is the Coordinator of the Spanish Headache Study Group of the Spanish Neurological Society (cefaleas.sen.es), she is a member of the International Headache Society Board of Trustees, the International Headache Society Clinical Trials Guidelines Committee and the European Headache Federation Council.
She is the Editor for Headache for Revista de Neurologia, an Associate Editor of Frontiers in Neurology (Headache Medicine) and a member of the Editorial Advisory Board of The Journal of Headache and Pain.
Dr. Pozo-Rosich’s research focuses on better understanding the pathophysiology of migraine from a multidisciplinary approach using genetics, neuroimaging and electrophysiology. She has developed the Migraine Adaptive Brain research program. In this regard, she is a member of the International Headache Genetics Consortium. She has been awarded research grants from the la Caixa Foundation, Fondo de Investigaciones Sanitarias (ISCIII), la Marató TV3 Foundation, AGAUR, Mutual Medica and, the Migraine Research Foundation.
She has been the principal investigator of clinical trials in phases II and III.
She educates neurologists, other physicians and patients with the goal of improving the quality of life of patients suffering from headache and helping reduce the stigma of migraine. She is the founder and developer of the website in Spanish dedicated to headache www.midolordecabeza.org for patients and physicians which has more than 5,800 registered users and more than 25,000 facebook followers.
University of Zurich, Switzerland
Dr. med. Katrin Rauen is Fellow of the European Board of Neurology, consultant in Neurology and Psychiatry at the Department of Geriatric Psychiatry, University Hospital of Psychiatry Zurich “Burghölzli”, scientifically specializing on the neuroinflammatory and neurodegenerative long-term sequels following Traumatic Brain Injury (TBI). Dr. Rauen is holding a dual affiliation as Principal Investigator to the Institute of Regenerative Medicine at the University of Zurich (IREM), Switzerland, as well as to the Institute of Stroke and Dementia Research (ISD) at the Ludwig-Maximilians-University, Munich, Germany.
The overarching goal of Dr. Rauen´s research is to elucidate the pathophysiology of chronic TBI and to elucidate biomarkers to better stratify patients being at risk for posttraumatic cognitive decline, thereby setting the basis for new anti-inflammatory and anti-dementia therapy. Furthermore, she aims to implement neuro-psychiatric diagnostic algorithm to early identify patients being at risk for psychiatric disorders to support patients and their caregivers to adapt to the posttraumatic condition and to regain best quality of life despite the lifechanging brain trauma.
Dr. Rauen received her M.D. in 2011 from Ludwig-Maximilians-University, Munich, Germany and gained international experience at the UCL Queens Square Institute of Neurology, London, England, at Kaiser Permanente Rehab Center, Vallejo, California, USA, and at the University of Stellenbosch, South Africa. Her doctoral thesis Influence of vasopressin receptors and aquaporins on secondary brain injury following experimental TBI at Professor Plesnila´s laboratory at LMU Munich was honored summa cum laude in 2014. Dr. Rauen received honors and awards from the German Society of Neurology, German Society of Neurosurgery, International Neurotrauma Society, German Society of Neuroscience, European Academy of Neurology and European Brain Injury Consortium (EBIC). She is part of the ERA-Net Neuron CnsAflame TBI consortium on neuroinflammatory mechanisms following TBI and executive board member of the Women´s Brain Project to elucidate sex and gender differences following TBI.
University of Lucern, Switzerland
Sara is Assistant Professor of Health Communication at the Department of Health Sciences and Health Policy of the University of Lucerne (CH), and Leader of the Person-Centered/Health Communication Group at Swiss Paraplegic Research (CH). She is currently the President of the International Association for Communication in Healthcare (EACH), and scientific consultant for the World Health Organization. Her background is in philosophy, rhetoric, argumentation theory and persuasion research, theories and models of communication, information and education, human empowerment and critical thinking, with a specific focus on healthcare and qualitative research.
Consultant in Neurology, Deputy head of Ambulatory University Neurocenter, Head of Ambulatory Infusion Unit, Inselspital, Bern University Hospital and University of Bern, Switzerland
Anke Salmen, MD, is a clinical neuroscientist with a focus on translational Neuroimmunology. She did her training in neurology in Bochum, Germany (Prof. Gold). Since 2016, she works as a consultant in Neurology at the Inselspital, Bern University Hospital (Prof. Bassetti) as head of the Neuroimmunology out-patient clinics and ambulatory infusion unit and since 2018 as the deputy head of the Ambulatory University Neurocenter. Her scientific focus are clinical and translational neuroscience projects in Multiple Sclerosis and related disorders, e.g. antibody-driven CNS autoimmunity. She is highly experienced in the conduct of cohort studies and registries and has recently published epidemiological data on MS in Switzerland, inter alia on age-dependent variation of female preponderance in MS.
Antonella Santuccione Chadha
CEO, WBP; Roche Diagnostics, Switzerland
Dr. Antonella Santuccione Chadha is a medical doctor with profound expertise in clinical pathology, neuroscience and psychiatric disorders. Currently she works as an Global Medical Manager for Alzheimer’s disease at Roche Diagnostic. She is a co-founder and CEO of the non-profit organization “Women’s Brain Project” which is addressing the influence of sex and gender on mental disorders and novel technologies. As a medical doctor, Antonella has decades of experience in preclinical research, patient treatment, clinical development, and setting up the international regulatory framework for Alzheimer’s disease. Always focused on solving the puzzles related to Alzheimers and other psychiatric diseases, she has worked with Swissmedic, the Bill and Melinda Gates Foundation, several European universities, the EU commission for Health and Food Safety, the World Health Organization and several Alzheimer’s’ disease Organizations. Antonella has been nominated in 2018 among the TOP 100 Women in Business in Switzerland and in 2019 as the most prominent people in the city of Basel. Antonella Santuccione Chadha is keenly interested in removing bias so that precision medicines and novel technologies can be delivered to patients in a more precise and timely manner. She is advocating and acting for the creation of an Institute for sex and gender precision medicine in Switzerland.
Annemarie Schumacher Dimech
President, WBP, Switzerland
Annemarie serves as President of the Women’s Brain Project and is also one of the organization’s co-founders. Her strong interest in mental health issues and caregiving started in Malta where she obtained a Bachelor’s degree in psychology. Later she studied health psychology at the University of Surrey (UK) before spending a few years working with children with mental and/or physical disability and their families. Annemarie moved to Switzerland in 2005, and obtained her PhD at the University of Bern. She worked as a researcher and teacher in the area of health and exercise psychology for over ten years. Today she is employed at the University of Lucerne to develop and head the new Certificate of Advanced Studies in Comprehensive Palliative Care.
Science Lead and CTO of Lavendr, Switzerland
Dr. Stavros Skouras is the Science Lead and CTO of Lavendr, a spin-off from Ricolab, the radical innovation lab of Ricola. Starting with Artificial Intelligence and Psychology at the University of Edinburgh, Dr. Skouras obtained a PhD in Affective Neuroscience from Freie Universität Berlin. For over 10 years, he taught Research Methods, Cognitive Programming and Diagnostic Imaging in world-class universities. More recently he was awarded a prestigious grant from the European Commission to work on developing virtual reality and neurofeedback technology for Alzheimer’s prevention. He possesses extensive knowledge in clinical studies, data science and medical imaging, as well as a history of pro-bono work for positive societal impact.
Silvina Catuara Solarz
Silvina Catuara Solarz, Telefonica Innovation Alpha, Spain
Silvina Catuara Solarz is the Strategy Manager at the Health Moonshot at Telefonica Innovation Alpha. She holds a PhD in Translational Neuroscience from the Pompeu Fabra University that she developed at the Centre for Genomic Regulation (CRG) and the Hospital del Mar Research Institute (IMIM), Barcelona, Spain, in 2016. She has experience in experimental and clinical research on neurodevelopmental and neurodegenerative disorders using digital assessment and interventions.
Her main interests include the application of digital technologies and artificial intelligence to prevent and manage mental and physical conditions.
PharmD Senior Pharmacist FDA Office of Women’s Health, USA
Erin South, PharmD, serves as Senior Pharmacist in the US Food and Drug Administration Office of Women’s Health (FDA OWH), which provides the Commissioner and senior agency leadership with expertise, advice, and guidance on scientific, ethical, and policy issues relating to women’s health. Erin leads multiple projects on the Scientific Programs team to support the inclusion of women in clinical trials, the implementation of guidelines concerning the representation of women in clinical trials, and data analyses by sex/gender. Erin coordinates a scientific educational lecture series targeted to FDA reviewers and open to attendees from across the US Department of Health and Human Services, providing educational programming based on scientific evidence and consideration of sex and gender differences to address knowledge gaps and support regulatory decision-making. Before assuming her current role, Erin served as a senior reviewer in FDA’s Center for Drug Evaluation and Research, in the Office of Surveillance and Epidemiology, where she provided expertise and recommendations on requirements related to risk evaluation and mitigation strategies (REMS) for both pre-marketed and post-marketed drug products. Erin received her BPharm from Albany College of Pharmacy and Health Sciences and PharmD from Shenandoah University. Her professional experience includes 20 years of community and clinical pharmacy and, outside of her duties at FDA, she continues clinical practice in a part time capacity.
Health Policy Analyst at OECD, France
Elina Suzuki is a policy analyst in the Health Division at the Organisation for Economic Co-operation and Development (OECD). Her work focuses on projects related to dementia, ageing, long-term care, and the use of new digital tools for healthcare. The OECD recently launched Care Needed: Improving the Lives of People with Dementia, a report presenting the most up-to-date and comprehensive cross-country assessment of the state of dementia care in OECD countries. Elina was formerly based at SEEK Development in Berlin, where she worked with a range of organisations and international institutions on issues of health financing and global health governance. She graduated from McGill University and received her master’s degree from the Harvard School of Public Health.
Royal Melbourne Hospital, Australia
Professor Szoeke is the Director of the Women’s Healthy Ageing Project. She led the research program in Neurodegenerative Diseases, Mental Disorders and Brain Health at the Australian Commonwealth Science and Industry Organisation (CSIRO) and then became a Clinical Consultant to CSIRO.
She a practicing neurologist with an honours degree in Genetics and Pharmacology, MBBS and FRACP with specialisation in Neurology and subspecialisation in Epileptology. She completed her PhD thesis in Epidemiology examining women’s healthy ageing and her post doctoral studies conducted between Stanford University and the University of Melbourne focussed on cognition.
She has been in clinical research for over a decade with over 300 publications, is a reviewer for national and international journals.
WBP Global Forum Ambassador, Film Director/Actress/Producer, Activist, UK
Fagun Thakrar is a critically acclaimed British Actress, Writer-Director and Activist who has appeared in a number of Hollywood and international films and has starred alongside Academy award winner Brie Larson, Donald Sutherland and Martin Sheen. Fagun studied Medicine at the University College London, this is where her interest in neuroscience started. Fagun is currently directing a first-of-its-kind documentary film on the intersection between meditation and neuroscience. As an artist Fagun is particularly drawn to cinematic roles with strong intellectual content that communicate a broader social message. As a writer-director Fagun similarly engages in projects which educate people’s perspectives on the world. Fagun has always been actively involved in local level and global non-profit work with children, girls, women and the health sector. She has worked with The United Nations, Amnesty International and others. She has established herself as a global champion of health and wellbeing throughout the world, working with disadvantaged children to world leaders and national presidents. Fagun has also recently founded her own global non-profit, The Fagun Foundation, dedicated to empowering girls and women worldwide to overcome barriers in their educational, professional, and personal lives through using creativity. Fagun lives between the UK and the US. After medical school, Fagun trained in Classical and Contemporary Acting at the prestigious Royal Central School of Speech and Drama in London and then went on to study film directing in US. In addition to her non-profit and cinematic profession, her career achievements also span a wide range of industries and passions including fashion, business and teaching. .
Founder Research Center for Computational Biomarkers, BiHELab, Greece
Dr. Panayiotis Vlamos is a Professor and Head of the Department of Informatics, Ionian University, with Diploma in Mathematics from the University of Athens and Ph.D. in Mathematics from the Department of Mathematics of National Technical University of Athens. He is also Director of the Bioinformatics and Human Electrophysiology Laboratory (BiHeLab). His research interests mainly concern protocols for early diagnosis of neurogenerative disease associated with mitochondrial dysfunctions and control mild cognitive disorder, mathematical modeling in Bioinformatics, algorithms on recent advances in Neuroinformatics, image restoration problems and physical- chemical engineering problems. He has (co-) authored more than 130 papers in international journals, conferences and book chapters. He is also (co-) author of more than 16 educational books and creator of several educational materials. He has been the principal researcher or a member of several research projects on Mathematical Modeling and Simulation.
Research and Policy Project Lead Alzheimer’s Disease International, UK
Wendy Weidner As Research and Policy Project Lead for Alzheimer’s Disease International (ADI), Wendy leads on ADI’s participation in the STRiDE (Strengthening responses to dementia in developing countries) project in partnership with the London School of Economics and Political Sciences (LSE) Personal Social Services Research Unit (PSSRU), universities and Alzheimer associations in seven countries in Asia, Africa, and the Americas. Her role also includes a focus on other research that ADI is involved in, including developing research webinars to provide a public interface between Alzheimer Associations and professionals providing dementia research in either biopsychosocial interventions or clinical trials. Wendy also works alongside ADI’s Medical and Scientific Advisory Panel. Before joining ADI, Wendy was the Business Development Manager for Dementia UK, where she led nationally on developing Admiral Nurse services, working closely with commissioners and other care providers to design new services that provided holistic and family-centred dementia care, while also providing social return on investment. Wendy also headed up a Dementia Pilot Project that looked at the impact of reminiscing with people with dementia. Wendy studied development economics and previously worked in project and service development and evaluation throughout Africa with the non-profit sector.